|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
SLCTR |
|
Last refreshed on:
|
27 April 2013 |
|
Main ID: |
SLCTR/2007/010 |
|
Date of registration:
|
21/09/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of diuretic actions of frusemide
with Ayurvedic diuretics
|
|
Scientific title:
|
A controlled trial to compare the diuretic action of frusemide with the Ayurvedic diuretic medicinal preparations Gokshura guggulu, Chandraprabhavatin and Vajrakshara |
|
Date of first enrolment:
|
1/10/2007 |
|
Target sample size:
|
100 patients (approx) |
|
Recruitment status: |
Completed |
|
URL:
|
http://www.slctr.lk/trial_details.asp?reg_id={E05BBEC2-B7AE-4879-B1B9-B8AFF920156C} |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised single blind prospective controlled trial
|
|
|
Countries of recruitment
|
|
Sri Lanka
| | | | | | | |
|
Contacts
|
|
Name:
|
Colvin Goonaratna
|
|
Address:
|
Faculty of Medicine
Kynsey Road
Colombo 8
|
|
Telephone:
|
4612643, 0773-488289 |
|
Email:
|
colvin_cg@yahoo.com |
|
Affiliation:
|
Professor |
|
|
Name:
|
Colvin Goonaratna
|
|
Address:
|
Faculty of Medicine
Kynsey Road
Colombo 8
|
|
Telephone:
|
4612643, 0773-488289 |
|
Email:
|
colvin_cg@yahoo.com |
|
Affiliation:
|
Professor |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients requiring diuretic therapy, but not seriously ill, giving voluntary informed consent
Exclusion criteria: Patients seriously ill
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Patients requiring diuretic therapy
|
|
Intervention(s)
|
|
Giving frusemide 40 mg orally and one of the three Ayurvedic preparations and assessing diuretic action by measuring urine flow rate,less thanBR>K+, Na+ and osmolar clearance.
|
|
Primary Outcome(s)
|
|
Effective diuresis
|
|
Secondary Outcome(s)
|
|
Adverse effects, patient preference
|
|
Source(s) of Monetary Support
|
|
National Science Foundation, Sri Lanka
|
|